STIM and ORAI proteins: Crucial roles in hallmarks of cancer

American Journal of Physiology - Cell Physiology

Volumn 310, Issue 7, 2016, Pages C509-C519

  Fiorio Pla, A ^a,b   Kondratska, K ^a   Prevarskaya, N ^a  

^a Université des Sciences et Technologies de Lille   (France)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Ca2+; Cancer; ORAI; STIM

Indexed keywords

CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; CALCIUM CHANNEL;

ANGIOGENESIS; APOPTOSIS; CALCIUM HOMEOSTASIS; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL FUNCTION; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; HUMAN; IMMUNE SYSTEM; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; CALCIUM SIGNALING; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; CALCIUM CHANNELS; CALCIUM SIGNALING; HUMANS; NEOPLASMS;

EID: 84982948439     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00364.2015     Document Type: Review

References (114)

1. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103: 1289–1299, 2008.
2. Akhmanova A, Steinmetz MO. Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol 9: 309–322, 2008.
3. Ambudkar IS. Calcium signalling in salivary gland physiology and dysfunction. J Physiol (Nov. 23, 2015). doi: 10.1113/JP271143. [Epub ahead of print].
4. Antigny F, Girardin N, Frieden M. Transient receptor potential canonical channels are required for in vitro endothelial tube formation. J Biol Chem 287: 5917–5927, 2012.
5. Arribas R, Ribas M, Risques RA, Masramon L, Tórtola S, Marcuello E, Aiza G, Miró R, Capellà G, Peinado MA. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Clin Cancer Res 5: 3454–3459, 1999.
6. Ay AS, Benzerdjeb N, Benzerdjerb N, Sevestre H, Ahidouch A, Ouadid-Ahidouch H. Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation. PLos One 8: e72889, 2013.
7. Aytes A, Molleví DG, Martinez-Iniesta M, Nadal M, Vidal A, Morales A, Salazar R, Capellà G, Villanueva A. Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype. Mol Carcinog 51: 746–753, 2012.
8. 2+ pump in proliferating human arterial myocytes. Am J Physiol Cell Physiol 297: C1103–C1112, 2009.
9. 2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer. Channels (Austin) 7: 379–391.
10. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11–21, 2000.
11. Bogeski I, Kummerow C, Al-Ansary D, Schwarz EC, Koehler R, Kozai D, Takahashi N, Peinelt C, Griesemer D, Bozem M, Mori Y, Hoth M, Niemeyer BA. Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. Sci Signal 3: ra24, 2010.
12. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, Capiod T. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 47: 2068–2077, 2008.
13. 2+ levels. Cell 131: 1327–1339, 2007.
14. Bussolati B, Grange C, Camussi G. Tumor exploits alternative strategies to achieve vascularization. FASEB J 25: 2874–2882, 2011.
15. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10: 417–427, 2011.
16. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438: 932–936, 2005.
17. Chantôme A, Potier-Cartereau M, Clarysse L, Fromont G, Marionneau- Lambot S, Guéguinou M, Pagès JC, Collin C, Oullier T, Girault A, Arbion F, Haelters JP, Jaffrès PA, Pinault M, Besson P, Joulin V, Bougnoux P, Vandier C. Pivotal role of the lipid raft SK3-Orai1 complex in human cancer cell migration and bone metastases. Cancer Res 73: 4852–4861, 2013.
18. Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY, Chang HC, Tang MJ, Shen MR. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci USA 108: 15225–15230, 2011.
19. Chen YT, Chen YF, Chiu WT, Liu KY, Liu YL, Chang JY, Chang HC, Shen MR. Microtubule-associated histone deacetylase 6 supports the calcium store sensor STIM1 in mediating malignant cell behaviors. Cancer Res 73: 4500–4509, 2013.
20. DeHaven WI, Smyth JT, Boyles RR, Putney JW. Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium releaseactivated calcium channels. J Biol Chem 282: 17548–17556, 2007.
21. 2+ influx regulates enolase-1 exteriorization. J Biol Chem 290: 11983–11999, 2015.
22. 2+ entry does not control proliferation in primary cultures of human metastatic renal cellular carcinoma. Biomed Res Int 2014: 739494, 2014.
23. Dubois C, Vanden Abeele F, Lehen’kyi V, Gkika D, Guarmit B, Lepage G, Slomianny C, Borowiec AS, Bidaux G, Benahmed M, Shuba Y, Prevarskaya N. Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. Cancer Cell 26: 19–32, 2014.
24. Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H, Ouadid- Ahidouch H. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J Cell Physiol 226: 542–551, 2011.
25. Faouzi M, Kischel P, Hague F, Ahidouch A, Benzerdjeb N, Sevestre H, Penner R, Ouadid-Ahidouch H. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. Biochim Biophys Acta 1833: 752–760, 2013.
26. Farfariello V, Iamshanova O, Germain E, Fliniaux I, Prevarskaya N. Calcium homeostasis in cancer: a focus on senescence. Biochim Biophys Acta 1853: 1974–1979, 2015.
27. 2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth. Carcinogenesis 33: 740–750, 2012.
28. Feldman B, Fedida-Metula S, Nita J, Sekler I, Fishman D. Coupling of mitochondria to store-operated Ca(2+)-signaling sustains constitutive activation of protein kinase B/Akt and augments survival of malignant melanoma cells. Cell Calcium 47: 525–537, 2010.
29. Feng M, Grice DM, Faddy HM, Nguyen N, Leitch S, Wang Y, Muend S, Kenny PA, Sukumar S, Roberts-Thomson SJ, Monteith GR, Rao R. Store-independent activation of Orai1 by SPCA2 in mammary tumors. Cell 143: 84–98, 2010.
30. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179–185, 2006.
31. 2+ entry in the immune system and beyond. Immunol Rev 231: 189–209, 2009.
32. Fiorio Pla A, Avanzato D, Munaron L, Ambudkar IS. Ion channels and transporters in cancer.
33. Vascularizing the tumor: TRP channels as molecular targets. Am J Physiol Cell Physiol 302: C9–C15, 2012.
34. 2+ entry is involved in early steps of tumor angiogenesis. Mol Cancer Res 6: 535–545, 2008.
35. Fiorio Pla A, Munaron L. Functional properties of ion channels and transporters in tumour vascularization. Philos Trans R Soc Lond B Biol Sci 369: 20130103, 2014.
36. Fiorio Pla A, Ong HL, Cheng KT, Brossa A, Bussolati B, Lockwich T, Paria B, Munaron L, Ambudkar IS. TRPV4 mediates tumorderived endothelial cell migration via arachidonic acid-activated actin remodeling. Oncogene 31: 200–212, 2012.
37. Flourakis M, Lehen’kyi V, Beck B, Raphaël M, Vandenberghe M, Abeele FV, Roudbaraki M, Lepage G, Mauroy B, Romanin C, Shuba Y, Skryma R, Prevarskaya N. Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. Cell Death Dis 1: e75, 2010.
38. González-Cobos JC, Zhang X, Zhang W, Ruhle B, Motiani RK, Schindl R, Muik M, Spinelli AM, Bisaillon JM, Shinde AV, Fahrner M, Singer HA, Matrougui K, Barroso M, Romanin C, Trebak M. Store-independent Orai1/3 channels activated by intracrine leukotriene C4: role in neointimal hyperplasia. Circ Res 112: 1013–1025, 2013.
39. Grigoriev I, Gouveia SM, van der Vaart B, Demmers J, Smyth JT, Honnappa S, Splinter D, Steinmetz MO, Putney JW, Hoogenraad CC, Akhmanova A. STIM1 is a MT-plus-end-tracking protein involved in remodeling of the ER. Curr Biol 18: 177–182, 2008.
40. 2+ (CRAC) channels. J Biol Chem 282: 19375–19384, 2007.
41. 2+ entry and NFAT activation in lymphocytes. Cell Calcium 42: 145–156, 2007.
42. Gwack Y, Srikanth S, Oh-Hora M, Hogan PG, Lamperti ED, Yamashita M, Gelinas C, Neems DS, Sasaki Y, Feske S, Prakriya M, Rajewsky K, Rao A. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 28: 5209–5222, 2008.
43. Hammadi M, Chopin V, Matifat F, Dhennin-Duthille I, Chasseraud M, Sevestre H, Ouadid-Ahidouch H. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol 227: 3837–3846, 2012.
44. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100: 57–70, 2000.
45. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144: 646–674, 2011.
46. Hogan PG, Rao A. Store-operated calcium entry: mechanisms and modulation. Biochem Biophys Res Commun 460: 40–49, 2015.
47. Hooper R, Samakai E, Kedra J, Soboloff J. Multifaceted roles of STIM proteins. Pflügers Arch 465: 1383–1396, 2013.
48. Hou X, Pedi L, Diver MM, Long SB. Crystal structure of the calcium release-activated calcium channel Orai. Science 338: 1308–1313, 2012.
49. Jardin I, Rosado JA. STIM and calcium channel complexes in cancer. Biochim Biophys Acta (Oct. 9, 2015). doi:10.1016/j.bbamcr.2015.10.003. [Epub ahead of print].
50. 2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation. Proc Natl Acad Sci USA 108: 19072–19077, 2011.
51. Kim JH, Lkhagvadorj S, Lee MR, Hwang KH, Chung HC, Jung JH, Cha SK, Eom M. Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma. Biochem Biophys Res Commun 448: 76–82, 2014.
52. Kondratska K, Kondratskyi A, Yassine M, Lemonnier L, Lepage G, Morabito A, Skryma R, Prevarskaya N. Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. Biochim Biophys Acta 1843: 2263–2269, 2014.
53. Kondratskyi A, Kondratska K, Skryma R, Prevarskaya N. Ion channels in the regulation of apoptosis. Biochim Biophys Acta 1848: 2532–2546, 2015.
54. 2+ current in human leukemic T cells. Cell Regul 1: 99–112, 1989.
55. Li G, Zhang Z, Wang R, Ma W, Yang Y, Wei J, Wei Y. Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest. J Exp Clin Cancer Res 32: 20, 2013.
56. Li J, Bruns AF, Hou B, Rode B, Webster PJ, Bailey MA, Appleby HL, Moss NK, Ritchie JE, Yuldasheva NY, Tumova S, Quinney M, McKeown L, Taylor H, Prasad KR, Burke D, O’Regan D, Porter KE, Foster R, Kearney MT, Beech DJ. Orai3 surface accumulation and calcium entry evoked by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 35: 1987–1994, 2015.
57. 2+ entry and endothelial tube formation. Circ Res 108: 1190–1198, 2011.
58. 2+ channels with distinct functional properties. Curr Biol 17: 794–800, 2007.
59. Liu H, Hughes JD, Rollins S, Chen B, Perkins E. Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis. Exp Mol Pathol 91: 753–760, 2011.
60. 2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients. PLos One 7: e42541, 2012.
61. Miederer AM, Alansary D, Schwär G, Lee PH, Jung M, Helms V, Niemeyer BA. A STIM2 splice variant negatively regulates storeoperated calcium entry. Nat Commun 6: 6899, 2015.
62. Mignen O, Shuttleworth TJ. I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. J Biol Chem 275: 9114–9119, 2000.
63. 2+-selective (ARC) channels without store depletion or translocation to the plasma membrane. J Physiol 579: 703–715, 2007.
64. Mignen O, Thompson JL, Shuttleworth TJ. Orai1 subunit stoichiometry of the mammalian CRAC channel pore. J Physiol 586: 419–425, 2008.
65. 2+-selective ARC channel is a pentameric assembly of Orai1 and Orai3 subunits. J Physiol 587: 4181–4197, 2009.
66. Monteith GR, Davis FM, Roberts-Thomson SJ. Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 287: 31666–31673, 2012.
67. 2+ transport. Nat Rev Cancer 7: 519–530, 2007.
68. Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem 285: 19173–19183, 2010.
69. Motiani RK, Hyzinski-García MC, Zhang X, Henkel MM, Abdullaev IF, Kuo YH, Matrougui K, Mongin AA, Trebak M. STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion. Pflügers Arch 465: 1249–1260, 2013.
70. 2+ channel that promotes tumorigenesis. FASEB J 27: 63–75, 2013.
71. 2+ signaling by promoting recruitment of STIM1 to the endoplasmic reticulum- plasma membrane junctions. Sci Signal 8: ra3, 2015.
72. Parekh AB, Putney JW. Store-operated calcium channels. Physiol Rev 85: 757–810, 2005.
73. Park CY, Hoover PJ, Mullins FM, Bachhawat P, Covington ED, Raunser S, Walz T, Garcia KC, Dolmetsch RE, Lewis RS. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 136: 876–890, 2009.
74. Parvez S, Beck A, Peinelt C, Soboloff J, Lis A, Monteilh-Zoller M, Gill DL, Fleig A, Penner R. STIM2 protein mediates distinct storedependent and store-independent modes of CRAC channel activation. FASEB J 22: 752–761, 2008.
75. Penna A, Demuro A, Yeromin AV, Zhang SL, Safrina O, Parker I, Cahalan MD. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 456: 116–120, 2008.
76. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 146: 873–887, 2011.
77. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230–233, 2006.
78. Prakriya M, Lewis RS. Store-Operated Calcium Channels. Physiol Rev 95: 1383–1436, 2015.
79. Prakriya M. Store-operated Orai channels: structure and function. Curr Top Membr 71: 1–32, 2013.
80. 2+ transport in cancer: how it contributes to cancer hallmarks? Philos Trans R Soc Lond B Biol Sci 369: 20130097, 2014.
81. Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11: 609–618, 2011.
82. Pupo E, Pla AF, Avanzato D, Moccia F, Cruz JEA, Tanzi F, Merlino A, Mancardi D, Munaron L. Hydrogen sulfide promotes calcium signals and migration in tumor-derived endothelial cells. Free Radic Biol Med 51: 1765–1773, 2011.
83. Rana A, Yen M, Sadaghiani AM, Malmersjö S, Park CY, Dolmetsch RE, Lewis RS. Alternative splicing converts STIM2 from an activator to an inhibitor of store-operated calcium channels. J Cell Biol 209: 653–669, 2015.
84. Rao W, Zhang L, Su N, Wang K, Hui H, Wang L, Chen T, Luo P, Yang Y, Liu Z, Fei Z. Blockade of SOCE protects HT22 cells from hydrogen peroxide-induced apoptosis. Biochem Biophys Res Commun 441: 351–356, 2013.
85. Raphaël M, Lehen’kyi V, Vandenberghe M, Beck B, Khalimonchyk S, Vanden Abeele F, Farsetti L, Germain E, Bokhobza A, Mihalache A, Gosset P, Romanin C, Clézardin P, Skryma R, Prevarskaya N. TRPV6 calcium channel translocates to the plasma membrane via Orai1- mediated mechanism and controls cancer cell survival. Proc Natl Acad Sci USA 111: E3870–E3879, 2014.
86. 2+ for cancer cell proliferation and survival. Nat Rev Cancer 8: 361–375, 2008.
87. 2+ entry in therapy resistant ovary carcinoma cells. Oncotarget 5: 4799–4810, 2014.
88. 2+ entry. Sci Signal 6: ra18, 2013.
89. Shuttleworth TJ. STIM and Orai proteins and the non-capacitative ARC channels. Front Biosci (Landmark Ed) 17: 847–860, 2012.
90. Smyth JT, Hwang SY, Tomita T, DeHaven WI, Mercer JC, Putney JW. Activation and regulation of store-operated calcium entry. J Cell Mol Med 14: 2337–2349, 2010.
91. Soboloff J, Rothberg BS, Madesh M, Gill DL. STIM proteins: dynamic calcium signal transducers. Nat Rev Mol Cell Biol 13: 549–565, 2012.
92. 2+ entry. Curr Biol 16: 1465–1470, 2006.
93. 2+ remodeling and cancer hallmarks in colorectal carcinoma cells. J Biol Chem 289: 28765–28782, 2014.
94. Stanisz H, Saul S, Müller CSL, Kappl R, Niemeyer BA, Vogt T, Hoth M, Roesch A, Bogeski I. Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry. Pigment Cell Melanoma Res 27: 442–453, 2014.
95. Sun Y, Cui X, Wang J, Wu S, Bai Y, Wang Y, Wang B, Fang J. Stromal interaction molecule 1 (STIM1) silencing inhibits tumor growth and promotes cell cycle arrest and apoptosis in hypopharyngeal carcinoma. Med Oncol 32: 150, 2015.
96. 2+ entry (SOCE) induced by protease-activated receptor-1 mediates STIM1 protein phosphorylation to inhibit SOCE in endothelial cells through AMP-activated protein kinase and p38βmitogen-activated protein kinase. J Biol Chem 288: 17030–17041, 2013.
97. 2+ entry. Biochem Biophys Res Commun 356: 45–52, 2007.
98. Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70: 5649–5669, 2010.
99. Teng MWL, Swann JB, Koebel CM, Schreiber RD, Smyth MJ. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol 84: 988–993, 2008.
100. Thompson JL, Shuttleworth TJ. A plasma membrane-targeted cytosolic domain of STIM1 selectively activates ARC channels, an arachidonate- regulated store-independent Orai channel. Channels (Austin) 6: 370–378, 2012.
101. 2+, diacylglycerol and STIM1 signalling system regulates directed cell migration. Nat Cell Biol 16: 133–144, 2014.
102. Vashisht A, Trebak M, Motiani RK. STIM and Orai proteins as novel targets for cancer therapy. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol 309: C457–C469, 2015.
103. Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of storeoperated calcium release-activated calcium channels. Nat Immunol 9: 89–96, 2008.
104. Weidinger C, Shaw PJ, Feske S. STIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cells. EMBO Mol Med 5: 1311–1321, 2013.
105. Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17: 1359–1370, 2011.
106. Williams RT, Manji SS, Parker NJ, Hancock MS, Van Stekelenburg L, Eid JP, Senior PV, Kazenwadel JS, Shandala T, Saint R, Smith PJ, Dziadek MA. Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J 357: 673–685, 2001.
107. Xu Y, Zhang S, Niu H, Ye Y, Hu F, Chen S, Li X, Luo X, Jiang S, Liu Y, Chen Y, Li J, Xiang R, Li N. STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer. Sci Rep 5: 11754, 2015.
108. Yang N, Tang Y, Wang F, Zhang H, Xu D, Shen Y, Sun S, Yang G. Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover. Cancer Lett 330: 163–169, 2013.
109. Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15: 124–134, 2009.
110. 2+ entry suppresses EGF-induced migration and eliminates extravasation from vasculature in nasopharyngeal carcinoma cell. Cancer Lett 336: 390–397, 2013.
111. 2+ store to the plasma membrane. Nature 437: 902–905, 2005.
112. Zhang W, Zhang X, González-Cobos JC, Stolwijk JA, Matrougui K, Trebak M. Leukotriene-C4 synthase, a critical enzyme in the activation of store-independent Orai1/Orai3 channels, is required for neointimal hyperplasia. J Biol Chem 290: 5015–5027, 2015.
113. Zhou Y, Ramachandran S, Oh-Hora M, Rao A, Hogan PG. Pore architecture of the ORAI1 store-operated calcium channel. Proc Natl Acad Sci USA 107: 4896–4901, 2010.
114. Zhu M, Chen L, Zhao P, Zhou H, Zhang C, Yu S, Lin Y, Yang X. Store-operated Ca(2+) entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation. J Exp Clin Cancer Res 33: 98, 2014.